Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Lo

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Ebiomedicine|September 4, 2018
Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trialMabel Toribio, Kathleen V Fitch, Lauren Stone, et al.
AIDS (London, England)|October 4, 2012
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllersFlorencia Pereyra, Janet Lo, Virginia A Triant, et al.
AIDS (London, England)|June 18, 2016
Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individualsKathleen V Fitch, Christopher DeFilippi, Robert Christenson, et al.
Nutrition & Diabetes|February 27, 2019
Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIVLindsay T Fourman, Emma M Kileel, Jane Hubbard, et al.
European Journal of Preventive Cardiology|March 30, 2013
Cost-effectiveness analysis of coronary artery disease screening in HIV-infected menJulia E H Nolte, Till Neumann, Jennifer M Manne, et al.
Endocrine|March 10, 2026
Identification of intranasal oxytocin plasma proteome signaturesLauren Breithaupt, Stephanie G Harshman, Patrick M Botros, et al.
Circulation. Cardiovascular Imaging|April 14, 2016
Relationship Between Measures of Adiposity, Arterial Inflammation, and Subsequent Cardiovascular EventsAmparo L Figueroa, Richard A P Takx, Megan H MacNabb, et al.
Open Forum Infectious Diseases|April 18, 2015
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographicsJonathan Z Li, Kelly B Arnold, Janet Lo, et al.
Circulation|June 21, 2008
Prevention strategies for cardiovascular disease in HIV-infected patientsJames H Stein, Colleen M Hadigan, Todd T Brown, et al.
Psychoneuroendocrinology|October 2, 2018
Amygdalar activity predicts future incident diabetes independently of adiposityMichael T Osborne, Amorina Ishai, Basma Hammad, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Ebiomedicine|September 4, 2018
Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trialMabel Toribio, Kathleen V Fitch, Lauren Stone, et al.
AIDS (London, England)|October 4, 2012
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllersFlorencia Pereyra, Janet Lo, Virginia A Triant, et al.
AIDS (London, England)|June 18, 2016
Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individualsKathleen V Fitch, Christopher DeFilippi, Robert Christenson, et al.
Nutrition & Diabetes|February 27, 2019
Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIVLindsay T Fourman, Emma M Kileel, Jane Hubbard, et al.
European Journal of Preventive Cardiology|March 30, 2013
Cost-effectiveness analysis of coronary artery disease screening in HIV-infected menJulia E H Nolte, Till Neumann, Jennifer M Manne, et al.
Endocrine|March 10, 2026
Identification of intranasal oxytocin plasma proteome signaturesLauren Breithaupt, Stephanie G Harshman, Patrick M Botros, et al.
Circulation. Cardiovascular Imaging|April 14, 2016
Relationship Between Measures of Adiposity, Arterial Inflammation, and Subsequent Cardiovascular EventsAmparo L Figueroa, Richard A P Takx, Megan H MacNabb, et al.
Open Forum Infectious Diseases|April 18, 2015
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographicsJonathan Z Li, Kelly B Arnold, Janet Lo, et al.
Circulation|June 21, 2008
Prevention strategies for cardiovascular disease in HIV-infected patientsJames H Stein, Colleen M Hadigan, Todd T Brown, et al.
Psychoneuroendocrinology|October 2, 2018
Amygdalar activity predicts future incident diabetes independently of adiposityMichael T Osborne, Amorina Ishai, Basma Hammad, et al.
Pageof 9